Once-daily fondaparinux monotherapy without warfarin for long-term treatment of venous thromboembolism.
Ranjith
R
Shetty
Ali
A
Seddighzadeh
Sudha
S
Parasuraman
Neelima G
NG
Vallurupalli
Marie
M
Gerhard-Herman
Samuel Z
SZ
Goldhaber
D000328:Adult; D000925:Anticoagulants / Q000008:administration & dosage* / Q000009:adverse effects; D004334:Drug Administration Schedule; D005240:Feasibility Studies; D005260:Female; D000077425:Fondaparinux; D006470:Hemorrhage / Q000139:chemically induced; D006801:Humans; D007279:Injections, Subcutaneous; D008297:Male; D008875:Middle Aged; D010865:Pilot Projects; D011134:Polysaccharides / Q000008:administration & dosage* / Q000009:adverse effects; D011446:Prospective Studies; D055502:Secondary Prevention; D016896:Treatment Outcome; D054556:Venous Thromboembolism / Q000188:drug therapy*
D000925:Anticoagulants; D011134:Polysaccharides; D000077425:Fondaparinux